The AI platform for optimized clinical development.

The AI platform for optimized clinical development.

Design and execute better trials with BlackCat Bio

Design and execute better trials with BlackCat Bio

Book a Demo

BlackCat Bio Team

Barbara Elashoff

I am a former FDA statistical reviewer who has reviewed hundreds of protocols and SAPs. I've also worked in pharma and biotech for the past 20 years. I have experience across a wide variety of therapeutic areas including pulmonary, autoimmune, metabolic, cardiovascular, dermatology and analgesia. I have a proven track record of successful regulatory submissions including NDAs, PMAs, 510(k)s, and BLAs.

View my CV

Publications

About Image
About Image
About Image

Shoham Das

AI-focused software engineer and data engineering leader with 7+ years of experience delivering scalable systems across biotech, healthcare, and venture. Skilled in building full-stack applications, data infrastructure, and AI-powered tools that support scientists, clinicians, and investors—spanning high-throughput experimentation, therapeutic discovery, and portfolio strategy.

Github

At Better Biostatistics, our mission is to deliver rigorous clinical insights without traditional bottlenecks. Blackcat Bio's AI tool is poised to be a game-changer for our network of consulting statisticians in achieving our mission. By ingesting complex study protocols, FDA interactions, and more, it will allow our biostatisticians to move straight to the high-level strategic refinement that matters most. We won't just save dozens of hours, we will ensure a higher baseline of consistency and quality across every project.

At Better Biostatistics, our mission is to deliver rigorous clinical insights without traditional bottlenecks. Blackcat Bio's AI tool is poised to be a game-changer for our network of consulting statisticians in achieving our mission. By ingesting complex study protocols, FDA interactions, and more, it will allow our biostatisticians to move straight to the high-level strategic refinement that matters most. We won't just save dozens of hours, we will ensure a higher baseline of consistency and quality across every project.

At Better Biostatistics, our mission is to deliver rigorous clinical insights without traditional bottlenecks. Blackcat Bio's AI tool is poised to be a game-changer for our network of consulting statisticians in achieving our mission. By ingesting complex study protocols, FDA interactions, and more, it will allow our biostatisticians to move straight to the high-level strategic refinement that matters most. We won't just save dozens of hours, we will ensure a higher baseline of consistency and quality across every project.

Robert Rachford, CEO, Better Biostatistics

See how BlackCat Bio can support your clinical trial.

Book a Demo

Contact Us